MT-ND6 gene mutation analysis in two Chinese patients with mitochondrial disease

Yu LIU,Chang-yu XIA,Ying ZHANG,Xue-fei ZHENG,Pei PEI,Hui-li ZHANG,Yi-nan MA,Yu QI
DOI: https://doi.org/10.13404/j.cnki.cjbhh.2017.04.006
2017-01-01
Abstract:Objective:To report the clinical and molecular genetic character of two Chinese mitochondrial patients with MT-ND6 mutation and explore the pathogenetic mechanism of mitochondrial DNA (mtDNA) mutation.Methods:The clinical information of patients was collected,and the common mtDNA mutations (such as A3243G,A8344G,T8993G/C and G13513A etc) were excluded.PCR-sequencing was used to analyze the whole-mitochondrial genome (16.6 kb).MitoTool was used to calculate the amino acid conservation rate,and PROVEAN,SIFT,PolyPhen-2 were used to predict and determine the function of missense mutation.Results:m.G14453A and m.T14325C mutation were found in proband 1 and proband 2 respectively,which both located in conserved region of MT-ND6.The in silico programs predicted that two mutations were "damaging".Both of them were not detected in their parents and 100 healthy controls.Conclusion:m.G14453A is a rare pathogenic mutation in MTND6,which is related with MELAS.m.T14325C is a candidate pathogenic mutation of LHON,however,the pathogenesis need to be studied further.The whole-mitochondrial gene sequencing has a significant application value in the diagnosis of mitochondrial disease,especially in some atypical and rare mitochondrial diseases.
What problem does this paper attempt to address?